Michael Vigman, Drug Discovery

mvigman@g.ucla.edu

 
 

Michael is a research associate in our Drug Discovery Program. He first joined the Nathanson Lab as an undergraduate researcher in 2021 and has since graduated from UCLA ('24) with a Molecular, Cell, and Developmental Biology BS and Biomedical Research minor. Currently, he is helping to develop next-generation potent and brain-penetrant tyrosine kinase inhibitors for glioblastoma (GBM). Specifically, he investigates DMPK/PD aspects of these novel inhibitors including brain penetrance and drug exposure, in vivo efficacy, protein reactivity, and dose tolerability. He is applying to medical schools in 2025.

 
 

Check out Michael’s Research Project